RNF41 and Cirrhosis: The diagnostic performance of RNF41 PMR values in distinguishing HBV-CLC from CHB significantly outperformed conventional indices including LSM, FIB-4, and APRI scores, suggesting that RNF41 methylation status in PBMCs may serve as a promising non-invasive diagnostic biomarker for early cirrhosis.